Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MLAB

Mesa Laboratories, Inc.

Dec 07 • 04:00PM ET

100.39

Dollar change +5.35
Percentage change 5.63	%

Technology • Scientific & Technical Instruments • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.13	Insider Own	3.97%	Shs Outstand	5.37M	Perf Week	17.59%
Market Cap	541.10M	Forward P/E	12.49	EPS next Y	8.04	Insider Trans	-4.04%	Shs Float	5.18M	Perf Month	7.58%
Income	-0.72M	PEG	-	EPS next Q	1.78	Inst Own	91.28%	Short Float / Ratio	5.67% / 6.90	Perf Quarter	-18.21%
Sales	213.69M	P/S	2.53	EPS this Y	-14.97%	Inst Trans	-1.59%	Short Interest	0.29M	Perf Half Y	-24.73%
Book/sh	72.22	P/B	1.39	EPS next Y	13.46%	ROA	-0.11%	Target Price	115.00	Perf Year	-42.22%
Cash/sh	6.61	P/C	15.19	EPS next 5Y	-	ROE	-0.19%	52W Range	82.86 - 206.36	Perf YTD	-39.60%
Dividend	0.64	P/FCF	14.88	EPS past 5Y	-	ROI	-0.13%	52W High	-51.35%	Beta	0.75
Dividend %	0.64%	Quick Ratio	2.13	Sales past 5Y	18.33%	Gross Margin	50.23%	52W Low	21.16%	ATR	5.00
Employees	698	Current Ratio	2.96	Sales Q/Q	-9.50%	Oper. Margin	1.56%	RSI (14)	61.08	Volatility	6.09% 5.49%
Optionable	No	Debt/Eq	0.45	EPS Q/Q	-193.76%	Profit Margin	-0.34%	Rel Volume	1.19	Prev Close	95.04
Shortable	Yes	LT Debt/Eq	0.44	Earnings	Nov 06 BMO	Payout	368.88%	Avg Volume	42.61K	Price	100.39
Recom	2.33	SMA20	11.64%	SMA50	5.23%	SMA200	-24.99%	Volume	50,886	Change	5.63%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line	$300
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$287
Oct-02-20	Initiated	JP Morgan	Neutral	$260
Dec-04-19	Initiated	Jefferies	Buy
Aug-26-19	Initiated	Evercore ISI	Outperform	$250
Jun-10-16	Downgrade	Sidoti	Buy → Neutral

Nov-06-23 09:10AM	Mesa Laboratories Inc (MLAB) Reports 9.5% Decrease in Q2 FY 2024 Revenues (GuruFocus.com)
08:13AM	Mesa Labs: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Mesa Labs Announces Second Quarter Results (GlobeNewswire)
Oct-16-23 03:00AM	Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform (GlobeNewswire)
Oct-03-23 08:00AM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
08:09AM	Loading…
Sep-22-23 08:09AM	Penumbra and Mesa Labs have been highlighted as Zacks Bull and Bear of the Day (Zacks)
06:20AM	Bear of the Day: Mesa Labs (MLAB) (Zacks)
Sep-15-23 01:10AM	Insider Sell: Director John Schmieder Sells 3,000 Shares of Mesa Laboratories Inc (GuruFocus.com)
Sep-13-23 01:37PM	Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023 (GlobeNewswire)
Sep-11-23 11:21AM	15 Worst Performing Growth Stocks in 2023 (Insider Monkey)
Aug-24-23 04:02PM	Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions (GlobeNewswire)
Aug-10-23 01:32AM	Heres Why Mesa Laboratories (MLAB) Declined in Q2 (Insider Monkey)
Aug-03-23 09:35AM	Mesa Labs (MLAB) Surpasses Q1 Earnings Estimates (Zacks) +5.23%
08:27AM	Mesa Labs: Fiscal Q1 Earnings Snapshot (AP Finance)
08:00AM	Mesa Labs Announces First Quarter Results (GlobeNewswire)
07:50AM	Loading…
Jul-31-23 07:50AM	Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Intrinsic Value Is Potentially 32% Above Its Share Price (Simply Wall St.)
Jul-05-23 03:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Jun-21-23 08:00PM	MLAB: Lowering target price to $138.00 (Argus Research)
11:50AM	Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023 (GlobeNewswire)
May-25-23 09:25AM	Mesa Labs (MLAB) Q4 Earnings and Revenues Miss Estimates (Zacks)
08:14AM	Mesa Labs: Fiscal Q4 Earnings Snapshot (AP Finance)
08:00AM	Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results (GlobeNewswire)
May-22-23 01:16PM	Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking (Simply Wall St.)
May-02-23 06:23AM	Mesa Laboratories (NASDAQ:MLAB) Is Reinvesting At Lower Rates Of Return (Simply Wall St.)
Apr-26-23 08:00PM	MLAB: Lowering target price to $169.00 (Argus Research)
Apr-03-23 06:15PM	Mesa Labs (MLAB) Stock Sinks As Market Gains: What You Should Know (Zacks)
06:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
07:42AM	Investors in Mesa Laboratories (NASDAQ:MLAB) have unfortunately lost 33% over the last year (Simply Wall St.)
Mar-13-23 08:00AM	Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure (GlobeNewswire)
Mar-09-23 08:00AM	Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023 (GlobeNewswire)
05:36AM	Loading…
Feb-21-23 05:36AM	A Look At The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB) (Simply Wall St.)
Feb-14-23 09:00AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks) -7.32%
Feb-13-23 12:45PM	Is Mesa Labs (MLAB) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
08:00AM	Mesa Labs Releases Environmental, Social, and Governance Program Brochure (PR Newswire)
Feb-06-23 09:55AM	Mesa Labs (MLAB) Tops Q3 Earnings Estimates (Zacks) -9.08%
08:36AM	Mesa Labs Announces Third Quarter Results (GlobeNewswire)
Feb-01-23 12:43PM	What's in the Cards for Mesa Laboratories' (MLAB) Q3 Earnings? (Zacks)
06:43AM	Is Mesa Laboratories (MLAB) a Growing Stock? (Insider Monkey)
Jan-27-23 06:00PM	Mesa Labs (MLAB) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-19-23 06:15PM	Mesa Labs (MLAB) Gains As Market Dips: What You Should Know (Zacks)
Jan-17-23 04:33PM	Royce Investment Partners: Small-Cap Premier Quality Strategy--4Q22 Update and Outlook (GuruFocus.com)
Jan-13-23 06:00PM	Mesa Labs (MLAB) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-12-23 09:40AM	Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-11-23 06:26AM	Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) ROE Of 1.9% Concerning? (Simply Wall St.)
Jan-09-23 06:15PM	Mesa Labs (MLAB) Gains As Market Dips: What You Should Know (Zacks)
Jan-03-23 05:00PM	Mesa Labs Declares Quarterly Dividend (GlobeNewswire)
Dec-28-22 06:51AM	Mesa Labs and Eldorado Gold have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:20AM	Bull of the Day: Mesa Labs (MLAB) (Zacks)
Dec-18-22 04:48PM	Heres Why Mesa Laboratories (MLAB) Declined in Q3 (Insider Monkey)
Dec-16-22 11:59AM	Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023 (GlobeNewswire)
Nov-23-22 12:20PM	Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy? (Zacks)
Nov-17-22 08:04AM	Mesa Labs Acquires Belyntics Peptide Purification Business (GlobeNewswire)
Nov-08-22 06:48AM	Mesa Laboratories Second Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
Nov-04-22 03:49PM	Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director (GlobeNewswire) +9.86%
Nov-03-22 10:25AM	Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates (Zacks) +15.27%
08:00AM	Mesa Labs Announces Second Quarter Results (GlobeNewswire)
Oct-25-22 06:32AM	Further weakness as Mesa Laboratories (NASDAQ:MLAB) drops 7.8% this week, taking one-year losses to 60% (Simply Wall St.) +7.38%
Oct-03-22 02:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Sep-11-22 08:33AM	Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate (Simply Wall St.)
Aug-04-22 11:05AM	Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates (Zacks)
08:00AM	Mesa Labs Announces First Quarter Results (GlobeNewswire)
Jul-28-22 10:03AM	Mesa Labs (MLAB) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)
Jul-06-22 07:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Jun-27-22 08:01AM	Mesa Laboratories Appoints Tony Tripeny to its Board of Directors (GlobeNewswire)
May-31-22 09:25AM	Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
08:00AM	Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results (GlobeNewswire)
May-13-22 10:17AM	The five-year decline in earnings for Mesa Laboratories NASDAQ:MLAB) isn't encouraging, but shareholders are still up 55% over that period (Simply Wall St.)
Apr-12-22 09:51AM	News Flash: Analysts Just Made A Captivating Upgrade To Their Mesa Laboratories, Inc. (NASDAQ:MLAB) Forecasts (Simply Wall St.)
Apr-06-22 01:10PM	Mesa Labs Declares Quarterly Dividend (GlobeNewswire)
Apr-04-22 12:02PM	Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 21% Above Their Intrinsic Value Estimate (Simply Wall St.)
Feb-03-22 09:25AM	Mesa Labs (MLAB) Q3 Earnings Miss Estimates (Zacks)
09:11AM	Are Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Mixed Financials Driving The Negative Sentiment? (Simply Wall St.)
08:00AM	Mesa Labs Announces Third Quarter Results (GlobeNewswire)
Jan-26-22 03:01PM	Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-06-22 03:00PM	MESA LABS DECLARES QUARTERLY DIVIDEND (GlobeNewswire)
Dec-21-21 08:01AM	Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare (Zacks)
07:12AM	My 3 Favorite Under-the-Radar Healthcare Stocks for 2022 (Motley Fool)
Dec-20-21 12:48PM	What History Shows Us About 2022 Market Returns (Zacks)
07:52AM	Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment? (Simply Wall St.)
Dec-16-21 10:47AM	Mesa Laboratories and Disney have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:20AM	Bull of the Day: Mesa Laboratories (MLAB) (Zacks)
Dec-11-21 09:15AM	Mesa Laboratories Inc (MLAB) CFO John Sakys Sold $570,893 of Shares (GuruFocus.com)
Nov-04-21 10:55AM	Mesa Labs (MLAB) Q2 Earnings and Revenues Surpass Estimates (Zacks)
08:00AM	Mesa Labs Announces Second Quarter Results (GlobeNewswire)
Oct-29-21 08:00AM	Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors (GlobeNewswire)
Oct-28-21 03:05PM	Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-21-21 09:35AM	Investors in Mesa Laboratories (NASDAQ:MLAB) have made a strong return of 153% over the past five years (Simply Wall St.)
Oct-20-21 12:05PM	Mesa Labs Closes Acquisition of Agena Bioscience (GlobeNewswire)
Oct-08-21 05:48AM	Mesa Labs, Equinox Gold, General Motors, Tesla and Ford Motor highlighted as Zacks Bull and Bear of the Day (Zacks)
05:20AM	Bull of the Day: Mesa Laboratories (MLAB) (Zacks)
Oct-01-21 03:00PM	Mesa Labs Declares Quarterly Dividend (GlobeNewswire)
Sep-14-21 01:02PM	Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M (Benzinga) +8.19%
07:50AM	Mesa Labs (MLAB) Moves 4.5% Higher: Will This Strength Last? (Zacks)
07:00AM	Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc. (GlobeNewswire)
Sep-13-21 11:49AM	Notable Mesa Laboratories Insider Trades $503.87 Thousand In Company Stock (Benzinga)
Aug-22-21 10:38AM	Can Mixed Financials Have A Negative Impact on Mesa Laboratories, Inc.'s 's (NASDAQ:MLAB) Current Price Momentum? (Simply Wall St.)
Aug-05-21 11:15AM	Mesa Labs (MLAB) Lags Q1 Earnings Estimates (Zacks)
08:00AM	Mesa Labs Announces First Quarter Results (GlobeNewswire)
Jul-29-21 03:05PM	Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-08-21 04:54AM	Mesa Laboratories (NASDAQ:MLAB) Has A Pretty Healthy Balance Sheet (Simply Wall St.)

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schmieder John Bradley	Director	Sep 15	Sale	123.74	1,000	123,740	62,760	Sep 19 12:34 PM
Schmieder John Bradley	Director	Sep 14	Sale	123.05	3,000	369,150	63,760	Sep 19 12:34 PM
Schmieder John Bradley	Director	Sep 13	Sale	123.32	3,000	369,965	66,760	Sep 14 01:47 PM
Owens Gary M	President and CEO	Sep 01	Option Exercise	136.42	2,000	272,840	32,032	Sep 05 04:34 PM
Owens Gary M	President and CEO	Sep 01	Sale	142.82	2,000	285,640	30,032	Sep 05 04:34 PM
Tripeny R Tony	Director	Aug 15	Option Exercise	0.00	1,105	0	1,605	Aug 16 03:54 PM
Ladiwala Shiraz Shabanali	Director	Aug 15	Option Exercise	0.00	1,055	0	1,460	Aug 16 03:45 PM
Ladiwala Shiraz Shabanali	Director	Aug 15	Option Exercise	0.00	40	0	1,500	Sep 06 12:36 PM
Sullivan John James	Director	Aug 15	Option Exercise	0.00	754	0	29,004	Aug 16 03:37 PM
Alltoft Jennifer Sadie	Director	Aug 15	Option Exercise	0.00	754	0	2,400	Aug 16 03:28 PM
Schmieder John Bradley	Director	Aug 15	Option Exercise	0.00	754	0	69,760	Aug 16 03:19 PM
Hall Shannon	Director	Aug 15	Option Exercise	0.00	754	0	1,711	Aug 16 02:03 PM
Owens Gary M	President and CEO	Jun 16	Option Exercise	0.00	2,820	0	30,992	Jun 21 01:22 PM
Archbold Brian David	SVP Operations	Jun 16	Option Exercise	0.00	612	0	2,247	Jun 21 12:23 PM
Sakys John	CFO	Jun 16	Option Exercise	0.00	848	0	11,019	Jun 21 12:02 PM
Sullivan John James	Director	Jun 16	Option Exercise	0.00	15	0	28,256	Jun 21 01:38 PM
Schmieder John Bradley	Director	Jun 15	Option Exercise	0.00	30	0	69,006	Jun 16 07:46 PM
Owens Gary M	CEO	Jun 15	Option Exercise	0.00	2,823	0	29,409	Jun 16 07:37 PM
Archbold Brian David	SVP Operations	Jun 15	Option Exercise	0.00	614	0	1,918	Jun 16 07:10 PM
Sakys John	CFO	Jun 15	Option Exercise	0.00	848	0	10,544	Jun 16 06:24 PM
Sullivan John James	Director	Jun 15	Option Exercise	0.00	15	0	28,247	Jun 16 07:56 PM
Sakys John	CFO	Mar 24	Option Exercise	85.13	2,128	181,147	10,824	Mar 27 09:40 AM
Sakys John	CFO	Mar 24	Sale	167.01	2,128	355,397	9,696	Mar 27 09:40 AM
Sakys John	CFO	Mar 22	Option Exercise	122.66	2,500	306,650	12,196	Mar 27 09:40 AM
Sakys John	CFO	Mar 22	Sale	171.62	2,500	429,050	9,696	Mar 27 09:40 AM
Sakys John	CFO	Mar 15	Option Exercise	70.56	1,000	70,560	10,696	Mar 16 02:42 PM
Sakys John	CFO	Mar 15	Sale	165.71	1,000	165,710	9,696	Mar 16 02:42 PM
Sakys John	CFO	Mar 09	Option Exercise	70.56	400	28,224	10,096	Mar 09 06:13 PM
Sakys John	CFO	Mar 09	Sale	169.97	400	67,988	9,696	Mar 09 06:13 PM
Sakys John	CFO	Feb 09	Option Exercise	51.85	1,000	51,850	10,696	Feb 09 08:04 PM
Sakys John	CFO	Feb 09	Sale	184.27	1,000	184,270	9,696	Feb 09 08:04 PM
Sakys John	CFO	Jan 23	Option Exercise	70.56	2,100	148,176	11,796	Jan 25 12:23 PM
Sakys John	CFO	Jan 23	Sale	210.19	2,100	441,399	9,696	Jan 25 12:23 PM
Schmieder John Bradley	Director	Jan 13	Sale	191.31	1,571	300,548	68,976	Jan 17 10:52 AM
Hall Shannon	Director	Dec 08	Sale	174.97	230	40,244	957	Dec 09 09:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MLAB

Mesa Laboratories, Inc.

Upgrade your FINVIZ experience